The Natural Course of Trichophyton Tonsurans Carriage and Infection: A Molecular and Biochemical Evaluation
NCT00224926 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 446
Last updated 2011-09-19
Summary
To explore carrier and infection status of T.tonsurans tinea capitis and characterize the host-pathogen interaction as it relates to the disease presentation. The general hypothesis for this study is as follows: the type of genotypic and phenotypic variant to which a child is exposed accounts for the presentation status observed in Trichophyton tonsurans infection.The global outcome of this investigation is to reveal potential new drug targets designed to improve treatment outcomes in these children.
Conditions
- Tinea Capitis
Interventions
- PROCEDURE
-
Scalp Brushing
sterile, soft-head toothbrush massaged on scalp
Sponsors & Collaborators
-
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
collaborator NIH -
Children's Mercy Hospital Kansas City
lead OTHER
Principal Investigators
-
Susan Rahman, PharmD · Children's Mercy Hosptials and Clinics
Eligibility
- Min Age
- 2 Years
- Max Age
- 5 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2003-09-30
- Completion
- 2005-09-30
Countries
- United States
Study Locations
More Related Trials
-
Safety of a Topical Antifungal Treatment for Tinea Cruris, Tinea Pedis and Tinea Corporis
NCT01349998 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy Comparison of Itraconazole Pulse Therapy and Terbinafine Therapy in Treatment of Tinea Capitis in Children.
NCT07068256 ·Status: COMPLETED ·Phase: NA
-
Comparison Between Continuous and Pulse Itraconazole in Tinea Capitis in Children
NCT07184203 ·Status: RECRUITING ·Phase: NA
-
Topical Antifungal Treatment for Tinea Pedis
NCT01396785 ·Status: COMPLETED ·Phase: PHASE3
-
Population Pharmacokinetics of Terbinafine in Children With Tinea Capitis
NCT07046988 ·Status: RECRUITING
-
Topical Antifungal Treatment for Tinea Cruris
NCT01342315 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Terbinafine and Itraconazole
NCT05881980 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Topical Antifungal Treatment for Tinea Pedis
NCT01396811 ·Status: COMPLETED ·Phase: PHASE3
-
Pediatric Subjects With Tinea Corporis
NCT02227290 ·Status: COMPLETED ·Phase: PHASE4
-
An Open Label Pharmacokinetic Study of Naftin for Tinea Corporis
NCT02466867 ·Status: COMPLETED ·Phase: PHASE4
-
Spread of Dermatophytes Among Families
NCT00233493 ·Status: COMPLETED
-
Multicenter Study of the Efficacy and Safety of Luliconazole Cream in Tinea Pedis (Athlete's Foot)
NCT00869336 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Product 33525 (Luliconazole Cream 1%) in Pediatric Participants With Tinea Corporis
NCT02767947 ·Status: COMPLETED ·Phase: PHASE4
-
Terbinafine Compared to Griseofulvin in Children With Tinea Capitis
NCT00117754 ·Status: COMPLETED ·Phase: PHASE3
-
Improving the Appearance of Skin and Hair in Patients Undergoing Valley Fever Treatment
NCT03618992 ·Status: TERMINATED ·Phase: NA
-
Phase III Efficacy and Safety Study of Miconazole Oil for Otomycosis
NCT05660382 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Investigate the Effects of Itraconazole on the Pharmacokinetics of BMS-986256 in Healthy Participants
NCT03950960 ·Status: COMPLETED ·Phase: PHASE1
-
Effect Of Ketoconazole On The Pharmacokinetics Of Tasocitinib (CP-690,550) In Healthy Volunteers
NCT01202240 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Determine the Effect of Ketoconazole on the Pharmacokinetics of GDC-0980
NCT01473316 ·Status: COMPLETED ·Phase: PHASE1
-
Terbinafine Compared to Griseofulvin in Children With Tinea Capitis
NCT00117767 ·Status: COMPLETED ·Phase: PHASE3
-
Topical Tolnaftate Stick for Tinea Pedis: An Open-Label Interventional Study
NCT07245667 ·Status: RECRUITING ·Phase: PHASE2
-
The Effect of Itraconazole on BCT197 Exposure in Healthy Male Participants
NCT03498170 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis
NCT02812771 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluate Safety and Efficacy of Naftifine Hydrochloride Gel 2% and Naftin® Gel 2% in Tinea Pedis
NCT02335255 ·Status: COMPLETED ·Phase: PHASE1
-
Two Week Study Evaluating Safety, Tolerability and Pharmacokinetics of Multiple Doses of JTK-853 in Healthy Subjects
NCT01473069 ·Status: TERMINATED ·Phase: PHASE1